Live Lung Donor Retrospective Study

计划入组 369 人 · 首次发布于 2007 年 11 月 4 日

RELIVE Informed Consent Study

计划入组 624 人 · 首次发布于 2012 年 12 月 5 日

RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial

计划入组 135 人 · 首次发布于 2025 年 2 月 7 日

Relivergen

XILIVE

Rehine-Leucine

RELIEV TECHNOLOGIES

France

Revive Therapeutics Ltd.

Canada

Reviva Pharmaceuticals

United States

Median Technologies' AI-Powered Lung Cancer Screening Software Achieves Clinical Trial Success

Median Technologies Submits FDA 510(k) Application for AI-Powered Lung Cancer Screening Software

Immunotherapy's "Sting in the Tail": Life-Threatening Toxicity Persists Long After Cancer Is Cured